BRWM
FLNA

B. Riley Wealth Management’s Filana Therapeutics FLNA Stock Holding History

B. Riley Wealth Management’s Portfolio FLNA Stock Details FLNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-4,115
Closed -$255K – 689
2021
Q3 		$255K Sell
4,115
-946
-19% -$79K 0.02% 494
2021
Q2 		$432K Buy
5,061
+226
+5% +$12.1K 0.05% 259
2021
Q1 		$217K Buy
+4,835
New +$190K 0.03% 354

Other funds holding FLNA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

B. Riley Wealth Management's FLNA Position: Q4 2021 in Review

B. Riley Wealth Management sold out of Filana Therapeutics (FLNA) in Q4 2021, closing a stake of 4,115 shares — an estimated $255K sold.

B. Riley Wealth Management first reported a position in FLNA in Q1 2021 and held it in 3 quarters. The position peaked at $432K in Q2 2021. 171 funds tracked by Wall St. Rank hold FLNA as of Q4 2021.

  • B. Riley Wealth Management reported no remaining Filana Therapeutics position as of Q4 2021 after selling out during the quarter.
  • B. Riley Wealth Management sold 4,115 Filana Therapeutics shares in Q4 2021, an estimated $255K.
  • B. Riley Wealth Management first reported a position in Filana Therapeutics in Q1 2021 and held it in 3 quarters.
  • B. Riley Wealth Management's Filana Therapeutics position peaked at $432K in Q2 2021.
  • 171 funds tracked by Wall St. Rank held Filana Therapeutics as of Q4 2021.

Based on B. Riley Wealth Management's 13F filing for Q4 2021, filed 10 Feb 2022.